Restricted accessResearch articleFirst published online 2015-06
Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses
In this study HIV-1 subtype C-infected adults demonstrated higher purifying selection on their viral populations in reverse transcriptase (RT) than infected children. This difference is likely explained by more mature cytotoxic T-lymphocyte responses in adults, which may have implications for the development of drug resistance in the RT region.
Get full access to this article
View all access options for this article.
References
1.
LarssonM, JinX, RamratnamB, et al.: A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol specific CD8 T cells in HIV-1-positive individuals. AIDS, 1999; 13:766.
2.
MooreCB, JohnM, JamesIR, et al.: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science, 2002; 296:1439.
3.
TiemessenCT and KuhnL: Immune pathogenesis of pediatric HIV-1 infection. Current HIV/AIDS Rep, 2006; 3:13–19.
4.
Menéndez-AriasLUIS, MasA, and DomingoE: Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review). Viral Immunol, 1998; 11(4):167–181.
5.
ImamichiT: Action of anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors. Curr Pharm Design, 2004; 10(32):4039–4053.
6.
SandbergK, et al.: HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol, 2003; 170(8):4403–4410.
7.
ShalekoffS, et al.: Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally infected infants and their mothers. AIDS (London, Engl), 2009; 23(7):789.
8.
WasikTJ, JagodzinskiPP, HyjekEM, et al.: Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol, 1997; 158(12):6029–6036.
9.
BurnsDN and MofensonLM: Paediatric HIV-1 infection. Lancet, 1999; 354:1–6.
10.
SaravananS, VidyaM, BalakrishananP, et al.: Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method. J Virol Methods, 2009; 159:211–216.
11.
AlcantaraLCJ, CassolS, LibinP, et al.: A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucl Acids Res, 2009; 37:634–642.
12.
www.hiv.lanl.gov/.
13.
Kosakovsky PondSL, FrostSDW, and MuseSV: HyPhy: Hypothesis testing using phylogenies. Bioinformatics, 2005; 21(5):676–679.
14.
JohnsonVA, CalvezV, GunthardHF, et al.: Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med, 2013; 21(1):6–14.
15.
Lamhamedi-CherradiS, Culmann-PenciolelliB, GuyB, et al.: Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS, 1992; 11:1249.
